Discover investment opportunities in Top 150 Bullish Stocks Today using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 150 Bullish Stocks Today using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 150 Bullish Stocks Today using our Smart AI Filter.
7 stocks found for "Top 150 Bullish Stocks Today"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.37 Risk measure | ±100.0% Price volatility | -11.5 Valuation | 0.00% Annual yield | |||
0.94 Risk measure | ±92.4% Price volatility | -8.7 Valuation | 0.00% Annual yield | |||
3.39 Risk measure | ±100.0% Price volatility | 24.1 Valuation | 0.00% Annual yield | |||
0.95 Risk measure | ±80.3% Price volatility | 15.4 Valuation | 7.49% Annual yield | |||
0.45 Risk measure | ±100.0% Price volatility | -137.7 Valuation | 0.00% Annual yield | |||
1.73 Risk measure | ±100.0% Price volatility | -12.2 Valuation | 0.00% Annual yield | |||
0.69 Risk measure | ±100.0% Price volatility | -87.1 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: Why might FuboTV (FUBO) appeal to growth-focused investors?
A: FuboTV (FUBO) operates in the rapidly growing streaming industry, capitalizing on the cord-cutting trend. Its focus on live sports streaming may attract a specific audience looking for niche content. While growth prospects are strong, investors should consider its financial sustainability and market competition.
Q: What environmental advantages does Oklo (OKLO) present?
A: Oklo (OKLO) focuses on developing advanced nuclear reactors. This could appeal to investors interested in sustainable energy solutions as nuclear energy produces low greenhouse gas emissions. However, investors should weigh regulatory risks and technological viability.
Q: What sector does Akero Therapeutics (AKRO) belong to, and why is it significant?
A: Akero Therapeutics (AKRO) operates in the biotechnology sector, focusing on innovative treatments for non-alcoholic steatohepatitis (NASH). The significance lies in this market's potential, as NASH is a growing global health issue, but regulatory approval and clinical success are critical factors.
Q: Is H&E Equipment Services (HEES) likely to benefit in an economic upturn?
A: H&E Equipment Services (HEES) could benefit in an economic upturn due to increased demand for construction and industrial equipment rentals. Its performance is often tied to construction sector health and related capital expenditure trends.
Q: What risks might investors face with OppFi (OPFI) stock?
A: OppFi (OPFI) faces risks associated with regulatory scrutiny and competition in the alternative finance sector. As a provider of personal loans, interest rate fluctuations and economic downturns could impact its loan performance and profitability.
Q: How does Agilon Health (AGL) fit into the healthcare sector?
A: Agilon Health (AGL) focuses on value-based healthcare solutions for seniors, aligning with trends towards cost-effective and quality healthcare. Investors may see appeal in its partnerships with physician groups, but should monitor policy changes and competitive landscape.